• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童复方磺胺甲恶唑最佳剂量的研究。

Studies on the optimal dosage of co-trimazine in children.

作者信息

Bergfors P G

出版信息

Infection. 1979;7 Suppl 4:S354-8. doi: 10.1007/BF01639013.

DOI:10.1007/BF01639013
PMID:511349
Abstract

There are many difficulties in creating a simple and useful dosage schedule for co-trimazine treatment in children. However, it has been possible to propose a schedule based on age. No advantage can be seen in choosing doses according to weight or other measures of body size. The schedule referred to as schedule B leads to levels of both sulphadiazine and trimethoprim that are as near the optimal as possible with respect to efficacy and side-effects.

摘要

为儿童制定简单且实用的复方磺胺甲恶唑治疗剂量方案存在诸多困难。然而,基于年龄制定一个方案是可行的。根据体重或其他身体尺寸指标来选择剂量并无优势。被称为方案B的剂量方案能使磺胺嘧啶和甲氧苄啶的血药浓度在疗效和副作用方面尽可能接近最佳水平。

相似文献

1
Studies on the optimal dosage of co-trimazine in children.儿童复方磺胺甲恶唑最佳剂量的研究。
Infection. 1979;7 Suppl 4:S354-8. doi: 10.1007/BF01639013.
2
A comparison of co-trimazine once daily and co-trimoxazole twice daily in treatment of urinary tract infections in children.每日一次的复方磺胺嘧啶与每日两次的复方新诺明治疗儿童尿路感染的比较。
J Antimicrob Chemother. 1982 Nov;10(5):453-8. doi: 10.1093/jac/10.5.453.
3
Comparative trial of sulphadiazine-trimethoprim (co-trimazine), co-trimoxazole and sulphamethizole in the treatment of uncomplicated urinary tract infections.磺胺嘧啶-甲氧苄啶(复方磺胺嘧啶)、复方新诺明与磺胺甲噻二唑治疗单纯性尿路感染的对比试验
N Z Med J. 1980 Jan 23;91(652):43-4.
4
Clinical pharmacokinetics of co-trimazine.复方磺胺甲恶唑的临床药代动力学。
Clin Pharmacokinet. 1986 Sep-Oct;11(5):372-86. doi: 10.2165/00003088-198611050-00003.
5
Clinical studies on co-trimazine in children.儿童复方磺胺甲恶唑的临床研究。
Infection. 1979;7 Suppl 4:S408-10. doi: 10.1007/BF01639023.
6
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.用于尿路感染的磺胺类药物-甲氧苄啶联合制剂的研发。第3部分:磺胺嘧啶和磺胺甲恶唑与甲氧苄啶联用的药代动力学特征。
Infection. 1979;7 Suppl 4:S371-81. doi: 10.1007/BF01639016.
7
Trimethoprim-sulphadiazine prophylaxis in children with vesico-ureteric reflux.甲氧苄啶-磺胺嘧啶对膀胱输尿管反流患儿的预防作用
Scand J Infect Dis. 1989;21(2):201-4. doi: 10.3109/00365548909039969.
8
Efficacy of Co-Trimazine in hospitalized patients with complicated and uncomplicated urinary tract infections.复方磺胺甲恶唑治疗复杂性和非复杂性尿路感染住院患者的疗效
J Int Med Res. 1980;8(5):354-7. doi: 10.1177/030006058000800510.
9
Plasma and urine concentrations of trimethoprim-sulphadiazine (co-trimazine) in children given one dose per day.每日服用一剂的儿童中,甲氧苄啶-磺胺嘧啶(复方磺胺甲恶唑)的血浆和尿液浓度。
Scand J Infect Dis. 1988;20(1):91-5. doi: 10.3109/00365548809117223.
10
Co-trimazine distribution in the canine prostate.复方磺胺嘧啶在犬前列腺中的分布。
Infection. 1979;7 Suppl 4:S345-8. doi: 10.1007/BF01639011.

引用本文的文献

1
Trimethoprim/sulphonamide: concluding remarks.甲氧苄啶/磺胺类药物:总结发言。
Infection. 1979;7 Suppl 4:S417-8. doi: 10.1007/BF01639026.
2
The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.甲氧苄啶及甲氧苄啶/磺胺类复方制剂的药代动力学,包括其在体内组织中的渗透情况。
Infection. 1979;7 Suppl 4:S330-41. doi: 10.1007/BF01639009.

本文引用的文献

1
Trimethoprim, a sulphonamide potentiator.甲氧苄啶,一种磺胺增效剂。
Br J Pharmacol Chemother. 1968 May;33(1):72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x.
2
Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.体液中磺胺类药物抑菌活性部分及其无活性代谢产物总量的定量测定。
Chemotherapy. 1972;17(1):1-21. doi: 10.1159/000220833.
3
In situ quantitative evaluation of thin-layer chromatograms in clinical and pharmaceutical analysis. I. Estimation of some sulfonamide derivatives in human urine.
临床与药物分析中薄层色谱图的原位定量评估。I. 人尿中某些磺胺类衍生物的测定
Res Commun Chem Pathol Pharmacol. 1974 Oct;9(2):339-57.